TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Karo Pharma Sverige AB
Closing information (x1000 DKK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 201,360 | 169,522 | 210,153 |
Financial expenses | 251 | 93 | 110 |
Earnings before taxes | -11,867 | -9,222 | -760 |
EBITDA | -11,412 | -60,967 | 5,996 |
Total assets | 215,466 | 221,434 | 112,860 |
Current assets | 214,940 | 220,603 | 78,778 |
Current liabilities | 58,757 | 49,335 | 80,829 |
Equity capital | 156,709 | 172,020 | 31,955 |
- share capital | 114 | 116 | 112 |
Employees (average) | 129 | 93 | 40 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 72.7% | 77.7% | 28.3% |
Turnover per employee | 1,561 | 1,823 | 5,254 |
Profit as a percentage of turnover | -5.9% | -5.4% | -0.4% |
Return on assets (ROA) | -5.4% | -4.1% | -0.6% |
Current ratio | 365.8% | 447.2% | 97.5% |
Return on equity (ROE) | -7.6% | -5.4% | -2.4% |
Change turnover | 35,047 | -48,038 | 771 |
Change turnover % | 21% | -22% | 0% |
Chg. No. of employees | 36 | 53 | 11 |
Chg. No. of employees % | 39% | 133% | 38% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.